Cite
Gietzen T, El-Battrawy I, Lang S, et al. Impact of ST-segment elevation on the outcome of Takotsubo syndrome. Ther Clin Risk Manag. 2019;15:251-258doi: 10.2147/TCRM.S180170.
Gietzen, T., El-Battrawy, I., Lang, S., Zhou, X. B., Behnes, M., Ansari, U., Borggrefe, M., & Akin, I. (2019). Impact of ST-segment elevation on the outcome of Takotsubo syndrome. Therapeutics and clinical risk management, 15251-258. https://doi.org/10.2147/TCRM.S180170
Gietzen, Thorsten, et al. "Impact of ST-segment elevation on the outcome of Takotsubo syndrome." Therapeutics and clinical risk management vol. 15 (2019): 251-258. doi: https://doi.org/10.2147/TCRM.S180170
Gietzen T, El-Battrawy I, Lang S, Zhou XB, Behnes M, Ansari U, Borggrefe M, Akin I. Impact of ST-segment elevation on the outcome of Takotsubo syndrome. Ther Clin Risk Manag. 2019 Feb 07;15:251-258. doi: 10.2147/TCRM.S180170. eCollection 2019. PMID: 30799924; PMCID: PMC6369855.
Copy
Download .nbib